EdgarLookup

Helmerich & Payne, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Helmerich & Payne, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-4.4%
Profit Margin
Net income ÷ revenue
-2.4%
Return on Assets
Net income ÷ assets
0.77x
Debt-to-Equity
Total liabilities ÷ equity
+35.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $3.75B Nov 21, 2025
FY2025 Sep 30, 2024 $2.76B Nov 21, 2025
FY2025 Sep 30, 2023 $2.87B Nov 21, 2025
FY2024 Sep 30, 2022 $2.06B Nov 13, 2024
FY2023 Sep 30, 2021 $1.22B Nov 8, 2023
FY2020 Sep 30, 2020 $208.27M Nov 20, 2020
FY2020 Jun 30, 2020 $317.36M Nov 20, 2020
FY2020 Mar 31, 2020 $633.64M Nov 20, 2020
FY2020 Dec 31, 2019 $614.66M Nov 20, 2020
FY2020 Sep 30, 2019 $649.05M Nov 20, 2020

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $3.68B Nov 21, 2025
FY2025 Sep 30, 2024 $2.75B Nov 21, 2025
FY2025 Sep 30, 2023 $2.86B Nov 21, 2025
FY2024 Sep 30, 2022 $2.05B Nov 13, 2024
FY2023 Sep 30, 2021 $1.21B Nov 8, 2023
FY2022 Sep 30, 2020 $1.76B Nov 17, 2022
FY2021 Sep 30, 2019 $2.79B Nov 18, 2021
FY2020 Sep 30, 2018 $2.47B Nov 20, 2020
FY2019 Sep 30, 2017 $1.79B Nov 15, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Sep 30, 2018 $696.83M Nov 16, 2018
FY2018 Jun 30, 2018 $648.87M Nov 16, 2018
FY2018 Mar 31, 2018 $577.48M Nov 16, 2018
FY2018 Dec 31, 2017 $564.09M Nov 16, 2018
FY2017 Sep 30, 2017 $532.30M Nov 22, 2017
FY2017 Jun 30, 2017 $498.56M Nov 22, 2017
FY2017 Mar 31, 2017 $405.28M Nov 22, 2017
FY2017 Dec 31, 2016 $368.59M Nov 22, 2017
FY2016 Sep 30, 2016 $331.71M Nov 23, 2016
FY2016 Jun 30, 2016 $366.49M Nov 23, 2016

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 ($163.70M) Nov 21, 2025
FY2025 Sep 30, 2024 $344.17M Nov 21, 2025
FY2025 Sep 30, 2023 $434.10M Nov 21, 2025
FY2024 Sep 30, 2022 $6.95M Nov 13, 2024
FY2023 Sep 30, 2021 ($326.15M) Nov 8, 2023
FY2020 Sep 30, 2020 ($58.96M) Nov 20, 2020
FY2020 Jun 30, 2020 ($45.60M) Nov 20, 2020
FY2020 Mar 31, 2020 ($420.54M) Nov 20, 2020
FY2020 Dec 31, 2019 $30.61M Nov 20, 2020
FY2020 Sep 30, 2019 $41.18M Nov 20, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $3.32M Nov 21, 2025
FY2025 Sep 30, 2024 $457.45M Nov 21, 2025
FY2025 Sep 30, 2023 $568.31M Nov 21, 2025
FY2024 Sep 30, 2022 $45.29M Nov 13, 2024
FY2023 Sep 30, 2021 ($428.55M) Nov 8, 2023
FY2020 Sep 30, 2020 ($75.43M) Nov 20, 2020
FY2020 Jun 30, 2020 ($57.58M) Nov 20, 2020
FY2020 Mar 31, 2020 ($518.54M) Nov 20, 2020
FY2020 Dec 31, 2019 $31.37M Nov 20, 2020
FY2020 Sep 30, 2019 $39.02M Nov 20, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $287.05M Nov 21, 2025
FY2025 Sep 30, 2024 $244.88M Nov 21, 2025
FY2025 Sep 30, 2023 $206.69M Nov 21, 2025
FY2024 Sep 30, 2022 $182.37M Nov 13, 2024
FY2023 Sep 30, 2021 $172.20M Nov 8, 2023
FY2022 Sep 30, 2020 $167.51M Nov 17, 2022
FY2021 Sep 30, 2019 $194.42M Nov 18, 2021
FY2020 Sep 30, 2018 $199.26M Nov 20, 2020
FY2019 Sep 30, 2017 $147.55M Nov 15, 2019
FY2018 Sep 30, 2016 $146.18M Nov 16, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $542.95M Nov 21, 2025
FY2025 Sep 30, 2024 $684.66M Nov 21, 2025
FY2025 Sep 30, 2023 $833.68M Nov 21, 2025
FY2024 Sep 30, 2022 $233.91M Nov 13, 2024
FY2023 Sep 30, 2021 $136.44M Nov 8, 2023
FY2022 Sep 30, 2020 $538.88M Nov 17, 2022
FY2021 Sep 30, 2019 $855.75M Nov 18, 2021
FY2020 Sep 30, 2018 $557.85M Nov 20, 2020
FY2019 Sep 30, 2017 $371.20M Nov 15, 2019
FY2018 Sep 30, 2016 $754.53M Nov 16, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $426.37M Nov 21, 2025
FY2025 Sep 30, 2024 $495.07M Nov 21, 2025
FY2025 Sep 30, 2023 $395.46M Nov 21, 2025
FY2024 Sep 30, 2022 $250.89M Nov 13, 2024
FY2023 Sep 30, 2021 $82.15M Nov 8, 2023
FY2022 Sep 30, 2020 $140.80M Nov 17, 2022
FY2021 Sep 30, 2019 $458.40M Nov 18, 2021
FY2020 Sep 30, 2018 $466.58M Nov 20, 2020
FY2019 Sep 30, 2017 $397.57M Nov 15, 2019
FY2018 Sep 30, 2016 $257.17M Nov 16, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $6.71B Nov 21, 2025
FY2025 Sep 30, 2024 $5.78B Nov 21, 2025
FY2024 Sep 30, 2023 $4.38B Nov 13, 2024
FY2023 Sep 30, 2022 $4.36B Nov 8, 2023
FY2022 Sep 30, 2021 $5.03B Nov 17, 2022
FY2021 Sep 30, 2020 $4.83B Nov 18, 2021
FY2020 Sep 30, 2019 $5.84B Nov 20, 2020
FY2019 Sep 30, 2018 $6.21B Nov 15, 2019
FY2018 Sep 30, 2017 $6.44B Nov 16, 2018
FY2017 Sep 30, 2016 $6.83B Nov 22, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2016 Sep 30, 2015 $2.25B Nov 23, 2016

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2024 Sep 30, 2024 $2.92B Nov 13, 2024
FY2024 Sep 30, 2023 $2.77B Nov 13, 2024
FY2024 Sep 30, 2022 $2.77B Nov 13, 2024
FY2024 Sep 30, 2021 $2.91B Nov 13, 2024
FY2023 Sep 30, 2020 $3.32B Nov 8, 2023
FY2022 Sep 30, 2019 $4.01B Nov 17, 2022
FY2021 Sep 30, 2018 $4.38B Nov 18, 2021
FY2020 Sep 30, 2017 $4.16B Nov 20, 2020
FY2019 Sep 30, 2016 $4.56B Nov 15, 2019
FY2018 Sep 30, 2015 $4.90B Nov 16, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $182.85M Nov 21, 2025
FY2025 Sep 30, 2024 $45.65M Nov 21, 2025
FY2024 Sep 30, 2023 $45.65M Nov 13, 2024
FY2023 Sep 30, 2022 $45.65M Nov 8, 2023
FY2022 Sep 30, 2021 $45.65M Nov 17, 2022
FY2021 Sep 30, 2020 $45.65M Nov 18, 2021
FY2021 Sep 30, 2019 $82.79M Nov 18, 2021
FY2020 Sep 30, 2018 $64.78M Nov 20, 2020
FY2020 Sep 30, 2017 $51.71M Nov 20, 2020
FY2018 Sep 30, 2016 $4.72M Nov 16, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $2.62B Nov 21, 2025
FY2025 Sep 30, 2024 $2.88B Nov 21, 2025
FY2024 Sep 30, 2023 $2.71B Nov 13, 2024
FY2023 Sep 30, 2022 $2.47B Nov 8, 2023
FY2022 Sep 30, 2021 $2.57B Nov 17, 2022
FY2021 Sep 30, 2020 $3.01B Nov 18, 2021
FY2020 Sep 30, 2019 $3.71B Nov 20, 2020
FY2019 Sep 30, 2018 $4.03B Nov 15, 2019
FY2018 Sep 30, 2017 $3.86B Nov 16, 2018
FY2017 Sep 30, 2016 $4.29B Nov 22, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $196.85M Nov 21, 2025
FY2025 Sep 30, 2024 $217.34M Nov 21, 2025
FY2025 Sep 30, 2023 $257.17M Nov 21, 2025
FY2024 Sep 30, 2022 $232.13M Nov 13, 2024
FY2023 Sep 30, 2021 $917.53M Nov 8, 2023
FY2022 Sep 30, 2020 $487.88M Nov 17, 2022
FY2021 Sep 30, 2019 $347.94M Nov 18, 2021
FY2020 Sep 30, 2018 $284.36M Nov 20, 2020
FY2019 Sep 30, 2017 $521.38M Nov 15, 2019
FY2018 Sep 30, 2016 $905.56M Nov 16, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $2.06B Nov 21, 2025
FY2025 Sep 30, 2024 $1.78B Nov 21, 2025
FY2022 Sep 30, 2022 $542.61M Nov 17, 2022
FY2022 Sep 30, 2021 $1.03B Nov 17, 2022
FY2021 Sep 30, 2020 $480.73M Nov 18, 2021
FY2020 Sep 30, 2019 $479.36M Nov 20, 2020
FY2019 Sep 30, 2018 $493.97M Nov 15, 2019
FY2018 Sep 30, 2017 $492.90M Nov 16, 2018
FY2016 Sep 30, 2016 $491.80M Nov 23, 2016
FY2015 Sep 30, 2015 $531.50M Nov 25, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 (1) Nov 21, 2025
FY2025 Sep 30, 2024 3 Nov 21, 2025
FY2025 Sep 30, 2023 4 Nov 21, 2025
FY2024 Sep 30, 2022 0 Nov 13, 2024
FY2023 Sep 30, 2021 (3) Nov 8, 2023
FY2020 Sep 30, 2020 0 Nov 20, 2020
FY2020 Jun 30, 2020 0 Nov 20, 2020
FY2020 Mar 31, 2020 (3) Nov 20, 2020
FY2020 Dec 31, 2019 0 Nov 20, 2020
FY2020 Sep 30, 2019 0 Nov 20, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 (1) Nov 21, 2025
FY2025 Sep 30, 2024 3 Nov 21, 2025
FY2025 Sep 30, 2023 4 Nov 21, 2025
FY2024 Sep 30, 2022 0 Nov 13, 2024
FY2023 Sep 30, 2021 (3) Nov 8, 2023
FY2020 Sep 30, 2020 0 Nov 20, 2020
FY2020 Jun 30, 2020 0 Nov 20, 2020
FY2020 Mar 31, 2020 (3) Nov 20, 2020
FY2020 Dec 31, 2019 0 Nov 20, 2020
FY2020 Sep 30, 2019 0 Nov 20, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 99.45M Nov 21, 2025
FY2025 Sep 30, 2024 98.76M Nov 21, 2025
FY2024 Sep 30, 2023 99.43M Nov 13, 2024
FY2023 Sep 30, 2022 105.29M Nov 8, 2023
FY2022 Sep 30, 2021 107.90M Nov 17, 2022
FY2021 Sep 30, 2020 107.49M Nov 18, 2021
FY2020 Sep 30, 2019 108.44M Nov 20, 2020
FY2019 Sep 30, 2018 108.99M Nov 15, 2019
FY2018 Sep 30, 2017 108.60M Nov 16, 2018
FY2017 Sep 30, 2016 108.08M Nov 22, 2017

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $100.74M Nov 21, 2025
FY2025 Sep 30, 2024 $168.46M Nov 21, 2025
FY2025 Sep 30, 2023 $201.46M Nov 21, 2025
FY2024 Sep 30, 2022 $107.40M Nov 13, 2024
FY2023 Sep 30, 2021 $109.13M Nov 8, 2023
FY2022 Sep 30, 2020 $260.34M Nov 17, 2022
FY2021 Sep 30, 2019 $313.42M Nov 18, 2021
FY2020 Sep 30, 2018 $308.43M Nov 20, 2020
FY2019 Sep 30, 2017 $305.52M Nov 15, 2019
FY2018 Sep 30, 2016 $300.15M Nov 16, 2018